UNSPSC 51372036: Morphine sulfate

This classification denotes an opioid analgesic with the molecular formula 2C17H19NO3.5H2O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X3P646A2J0, chemically known as 7,8-didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol but more generally known as morphine sulfate, which bears US NIH Compound Identifier 5288826. European Medicines Agency schedules Morphine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14597MIG.

UNSPSC 51372036 Morphine sulfate is a Commodity code that encompasses the procurement of pharmaceutical substances and related products by state and local government agencies for community health, pharmacy benefit programs, and institutional healthcare delivery. State and local buyers under this code include county health departments, state health and human services commissions, multistate cooperative purchasing alliances, and specialized pharmacy programs. The work solicited ranges from direct purchases of controlled and non-controlled pharmaceuticals to participation in statewide or multistate pharmaceutical supply contracts administered through authorized wholesalers and pharmacy benefit intermediaries. Purchases are typically tied to specific volume requirements, quarterly or ongoing delivery schedules, and compliance with federal drug manufacturing and supply-chain security standards including cGMP certification and DSCSA documentation.

Recent opportunities reflect activity across Florida, Texas, and Minnesota-led regional cooperative procurement. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026; response due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the county's community health building. The Texas Health and Human Services Commission released RFI HHS0017013 (posted April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program serving state agencies and self-insured health plans outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026; response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) to participating state and local facilities including Oregon, with contract effectiveness July 1, 2026. MMCAP weighted evaluation 75 percent on price competitiveness, 10 percent on fixed pricing, and 15 percent on administrative compliance including EDI capability and cGMP/DSCSA certification.